Copyright Reports & Markets. All rights reserved.

Global 3D Printing Pharmaceuticals Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global 3D Printing Pharmaceuticals Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 FDM
    • 1.3.3 SLS
    • 1.3.4 PB
    • 1.3.5 SLA
    • 1.3.6 SSE
    • 1.3.7 DPE
    • 1.3.8 DOD
    • 1.3.9 MDD
    • 1.3.10 MED
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global 3D Printing Pharmaceuticals Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Personalized Pharmacy
    • 1.4.3 Nutrients
  • 1.5 Global 3D Printing Pharmaceuticals Market Size & Forecast
    • 1.5.1 Global 3D Printing Pharmaceuticals Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global 3D Printing Pharmaceuticals Sales Quantity (2021-2032)
    • 1.5.3 Global 3D Printing Pharmaceuticals Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Triastek,Inc.
    • 2.1.1 Triastek,Inc. Details
    • 2.1.2 Triastek,Inc. Major Business
    • 2.1.3 Triastek,Inc. 3D Printing Pharmaceuticals Product and Services
    • 2.1.4 Triastek,Inc. 3D Printing Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Triastek,Inc. Recent Developments/Updates
  • 2.2 Aprecia
    • 2.2.1 Aprecia Details
    • 2.2.2 Aprecia Major Business
    • 2.2.3 Aprecia 3D Printing Pharmaceuticals Product and Services
    • 2.2.4 Aprecia 3D Printing Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Aprecia Recent Developments/Updates
  • 2.3 AstraZeneca
    • 2.3.1 AstraZeneca Details
    • 2.3.2 AstraZeneca Major Business
    • 2.3.3 AstraZeneca 3D Printing Pharmaceuticals Product and Services
    • 2.3.4 AstraZeneca 3D Printing Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 AstraZeneca Recent Developments/Updates
  • 2.4 FabRx
    • 2.4.1 FabRx Details
    • 2.4.2 FabRx Major Business
    • 2.4.3 FabRx 3D Printing Pharmaceuticals Product and Services
    • 2.4.4 FabRx 3D Printing Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 FabRx Recent Developments/Updates
  • 2.5 Multiply Labs
    • 2.5.1 Multiply Labs Details
    • 2.5.2 Multiply Labs Major Business
    • 2.5.3 Multiply Labs 3D Printing Pharmaceuticals Product and Services
    • 2.5.4 Multiply Labs 3D Printing Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Multiply Labs Recent Developments/Updates
  • 2.6 DiHeSys
    • 2.6.1 DiHeSys Details
    • 2.6.2 DiHeSys Major Business
    • 2.6.3 DiHeSys 3D Printing Pharmaceuticals Product and Services
    • 2.6.4 DiHeSys 3D Printing Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 DiHeSys Recent Developments/Updates
  • 2.7 Merck
    • 2.7.1 Merck Details
    • 2.7.2 Merck Major Business
    • 2.7.3 Merck 3D Printing Pharmaceuticals Product and Services
    • 2.7.4 Merck 3D Printing Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Merck Recent Developments/Updates
  • 2.8 Merck KGaA
    • 2.8.1 Merck KGaA Details
    • 2.8.2 Merck KGaA Major Business
    • 2.8.3 Merck KGaA 3D Printing Pharmaceuticals Product and Services
    • 2.8.4 Merck KGaA 3D Printing Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Merck KGaA Recent Developments/Updates
  • 2.9 TNO
    • 2.9.1 TNO Details
    • 2.9.2 TNO Major Business
    • 2.9.3 TNO 3D Printing Pharmaceuticals Product and Services
    • 2.9.4 TNO 3D Printing Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 TNO Recent Developments/Updates
  • 2.10 Therics
    • 2.10.1 Therics Details
    • 2.10.2 Therics Major Business
    • 2.10.3 Therics 3D Printing Pharmaceuticals Product and Services
    • 2.10.4 Therics 3D Printing Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Therics Recent Developments/Updates

3 Competitive Environment: 3D Printing Pharmaceuticals by Manufacturer

  • 3.1 Global 3D Printing Pharmaceuticals Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global 3D Printing Pharmaceuticals Revenue by Manufacturer (2021-2026)
  • 3.3 Global 3D Printing Pharmaceuticals Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of 3D Printing Pharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 3D Printing Pharmaceuticals Manufacturer Market Share in 2025
    • 3.4.3 Top 6 3D Printing Pharmaceuticals Manufacturer Market Share in 2025
  • 3.5 3D Printing Pharmaceuticals Market: Overall Company Footprint Analysis
    • 3.5.1 3D Printing Pharmaceuticals Market: Region Footprint
    • 3.5.2 3D Printing Pharmaceuticals Market: Company Product Type Footprint
    • 3.5.3 3D Printing Pharmaceuticals Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global 3D Printing Pharmaceuticals Market Size by Region
    • 4.1.1 Global 3D Printing Pharmaceuticals Sales Quantity by Region (2021-2032)
    • 4.1.2 Global 3D Printing Pharmaceuticals Consumption Value by Region (2021-2032)
    • 4.1.3 Global 3D Printing Pharmaceuticals Average Price by Region (2021-2032)
  • 4.2 North America 3D Printing Pharmaceuticals Consumption Value (2021-2032)
  • 4.3 Europe 3D Printing Pharmaceuticals Consumption Value (2021-2032)
  • 4.4 Asia-Pacific 3D Printing Pharmaceuticals Consumption Value (2021-2032)
  • 4.5 South America 3D Printing Pharmaceuticals Consumption Value (2021-2032)
  • 4.6 Middle East & Africa 3D Printing Pharmaceuticals Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global 3D Printing Pharmaceuticals Sales Quantity by Type (2021-2032)
  • 5.2 Global 3D Printing Pharmaceuticals Consumption Value by Type (2021-2032)
  • 5.3 Global 3D Printing Pharmaceuticals Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global 3D Printing Pharmaceuticals Sales Quantity by Application (2021-2032)
  • 6.2 Global 3D Printing Pharmaceuticals Consumption Value by Application (2021-2032)
  • 6.3 Global 3D Printing Pharmaceuticals Average Price by Application (2021-2032)

7 North America

  • 7.1 North America 3D Printing Pharmaceuticals Sales Quantity by Type (2021-2032)
  • 7.2 North America 3D Printing Pharmaceuticals Sales Quantity by Application (2021-2032)
  • 7.3 North America 3D Printing Pharmaceuticals Market Size by Country
    • 7.3.1 North America 3D Printing Pharmaceuticals Sales Quantity by Country (2021-2032)
    • 7.3.2 North America 3D Printing Pharmaceuticals Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe 3D Printing Pharmaceuticals Sales Quantity by Type (2021-2032)
  • 8.2 Europe 3D Printing Pharmaceuticals Sales Quantity by Application (2021-2032)
  • 8.3 Europe 3D Printing Pharmaceuticals Market Size by Country
    • 8.3.1 Europe 3D Printing Pharmaceuticals Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe 3D Printing Pharmaceuticals Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific 3D Printing Pharmaceuticals Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific 3D Printing Pharmaceuticals Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific 3D Printing Pharmaceuticals Market Size by Region
    • 9.3.1 Asia-Pacific 3D Printing Pharmaceuticals Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific 3D Printing Pharmaceuticals Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America 3D Printing Pharmaceuticals Sales Quantity by Type (2021-2032)
  • 10.2 South America 3D Printing Pharmaceuticals Sales Quantity by Application (2021-2032)
  • 10.3 South America 3D Printing Pharmaceuticals Market Size by Country
    • 10.3.1 South America 3D Printing Pharmaceuticals Sales Quantity by Country (2021-2032)
    • 10.3.2 South America 3D Printing Pharmaceuticals Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa 3D Printing Pharmaceuticals Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa 3D Printing Pharmaceuticals Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa 3D Printing Pharmaceuticals Market Size by Country
    • 11.3.1 Middle East & Africa 3D Printing Pharmaceuticals Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa 3D Printing Pharmaceuticals Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 3D Printing Pharmaceuticals Market Drivers
  • 12.2 3D Printing Pharmaceuticals Market Restraints
  • 12.3 3D Printing Pharmaceuticals Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of 3D Printing Pharmaceuticals and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of 3D Printing Pharmaceuticals
  • 13.3 3D Printing Pharmaceuticals Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 3D Printing Pharmaceuticals Typical Distributors
  • 14.3 3D Printing Pharmaceuticals Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global 3D Printing Pharmaceuticals market size was valued at US$ 396 million in 2025 and is forecast to a readjusted size of US$ 669 million by 2032 with a CAGR of 7.9% during review period.
    3D printing pharmaceuticals can be applied to the field of solid preparations, which are dominated by small molecule drugs. Compared with traditional solid preparations, 3D printing pharmaceuticals can better control drug release, improve drug efficacy, reduce drug side effects, and reduce dosing frequency.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global 3D Printing Pharmaceuticals market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global 3D Printing Pharmaceuticals market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global 3D Printing Pharmaceuticals market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global 3D Printing Pharmaceuticals market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global 3D Printing Pharmaceuticals market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for 3D Printing Pharmaceuticals
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global 3D Printing Pharmaceuticals market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Triastek,Inc., Aprecia, AstraZeneca, FabRx, Multiply Labs, DiHeSys, Merck, Merck KGaA, TNO, Therics, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    3D Printing Pharmaceuticals market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    FDM
    SLS
    PB
    SLA
    SSE
    DPE
    DOD
    MDD
    MED
    Market segment by Application
    Personalized Pharmacy
    Nutrients
    Major players covered
    Triastek,Inc.
    Aprecia
    AstraZeneca
    FabRx
    Multiply Labs
    DiHeSys
    Merck
    Merck KGaA
    TNO
    Therics
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe 3D Printing Pharmaceuticals product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of 3D Printing Pharmaceuticals, with price, sales quantity, revenue, and global market share of 3D Printing Pharmaceuticals from 2021 to 2026.
    Chapter 3, the 3D Printing Pharmaceuticals competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the 3D Printing Pharmaceuticals breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and 3D Printing Pharmaceuticals market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of 3D Printing Pharmaceuticals.
    Chapter 14 and 15, to describe 3D Printing Pharmaceuticals sales channel, distributors, customers, research findings and conclusion.

    Buy now